Diagenode, a Hologic company, is a leading global provider of complete solutions for epigenetics research, biological sample preparation, and diagnostics assays. It was acquired by Hologic, Inc in March 2021.
The company has developed a comprehensive approach to gain new insights into epigenetics studies. The company offers innovative Bioruptor® shearing and IP-Star® automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company's latest innovations include a unique, full automation system, the industry's most validated antibodies, the Megaruptor shearing system for long fragment generation in sequencing, and epigenetics assay services.
At Diagenode, our goal is to build products with pride and the highest level of performance. Our team of epigenetics experts develop products by getting feedback from our customers as well as the scientific and medical communities around us. We strive to develop superior and easy-to-use products to bring epigenetics research and diagnostics to new frontiers.
Epigenetics is playing a revolutionary role in life sciences research. Diagenode continually innovates solutions and provides the highest quality epigenetics tools available.
For more than 16 years, Diagenode Diagnostics has been designing, manufacturing and selling innovative real-time PCR kits for the detection of pathogens associated with various infections. Building on this expertise, Diagenode Diagnostics has developed strong partnerships with clinical microbiology laboratories as well as in vitro diagnostics companies around the world.
Diagenode Diagnostics offers a wide range of real-time PCR CE-IVD kits, in simplex or multiplex, for the detection of bacteria, parasites and viruses involved in STI, herpes infections, respiratory infections, meningitis and gastroenteritis.
Diagenode Diagnostics is currently focusing on Mycoplasma genitalium with a new CE-IVD marked real-time PCR kit detecting the strains resistant to macrolides (5 mutations, S-DiaMGResTM), in perfect synergy with the CE-IVD kit Mycoplasma genitalium / Trichomonas vaginalis (S-DiaMGTVTM).
The geneLEAD VIII, manufactured by PSS and distributed by Diagenode Diagnostics, is a new all-in-one molecular diagnostics platform designed with 8 independent tracks to carry out small series of tests (1,000 to 4,000 tests/year), from nucleic acid extraction to patient result in 1.5 hour.
Diagenode Diagnostics is ISO 13485 certified and also develops and manufactures customized molecular diagnostics tests, meeting the specific requirements of many major companies in the in vitro diagnostics market (e.g. product design, lyophilization, instrument compatibility, kit format, documentation, CE and FDA submission, distribution, PMS...).